怀孕
医学
胎儿
淋巴瘤
产科
化疗
孕早期
流产
外科
内科学
遗传学
生物
作者
Uri Abadi,Gideon Koren,Michael Lishner
标识
DOI:10.1016/j.hoc.2011.01.001
摘要
Treatment of pregnant women with chemotherapy may pose a risk to the fetus, raising therapeutic, ethical, moral, and social dilemmas. Publications on this issue are limited to retrospective series and case reports, thus further complicating decision making. Diagnosis and staging are usually performed as in nonpregnant women, but procedures that expose the fetus to radiation are excluded. Chemotherapy is not recommended in the first trimester to avoid fetal malformations . Thus, the option is either treatment delay or pregnancy termination. Later in pregnancy, treatment is often initiated without delay, with no apparent evidence of teratogenicity .
科研通智能强力驱动
Strongly Powered by AbleSci AI